Use of a composition comprising a compound against the EGF receptor and a drug neugcgm3 Ganglioside used to treat cancer； and kit comprising such compounds.
GONZALEZ PALOMO ADYS,CARR PEREZ ADRIANA,LEON MONZON KALET,BLANCO SANTANA RANCES,BARROSO ALVAREZ MARIA DEL CARMEN,MACIAS ABRAHAM AMPARO EMILIA,MONTERO CASIMIRO JOSE ENRIQUE
申请号：
CL2014001236
公开号：
CL2014001236A1
申请日:
2014.05.12
申请国别(地区):
CL
年份:
2014
代理人:
摘要：
The present invention relates to pharmaceutical compositions for the treatment of malignant tumors. Particularly those tumors that express EGFR and GM3 N- glycolyl ganglioside targets to enhance the therapeutic effect produced by separated therapies against these targets. The pharmaceutical compositions of the invention include antibodies and/or vaccines against each of the targets. Additionally the present invention relates to methods for applying the compositions of the invention.USO de una composición que comprende un compuesto contra el receptor de EGF y un compuesto contra el gangliosido NeuGcGM3, CARACTERIZADO porque sirve para preparar un medicamento útil en el tratamiento del cáncer
